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Background: Substantial progress has been made in the 
management of pediatric HIV infection in Ethiopia with the 
implementation of mother-to-child-prevention programs. Since the 
introduction of HAART in 2005, mortality among HIV-infected 
children has reduced while the rate of hospitalization was expected 
to rise. The purpose of this study, therefore, was to assess 
predictors of hospitalization in children on ART in seven university 
referral hospitals in Ethiopia. 
Methods: A prospective cohort study design was employed on 
children age 0-18 years as part of a multisite observational study.  
ART-experienced eligible and ART-naïve children with HIV/AIDS 
were enrolled into the Advanced Clinical Monitoring (ACM) till 
December 31, 2012 were included. From the database, information 
on hospitalization and other independent variables were extracted. 
Analysis was done using both SPSS for Windows version 16.0 and 
STATA. Descriptive analyses and modeling was done using logistic 
regression. 
Results: Of the 405 children on ART (174 experienced, 231 naive), 
86 (20.7%) were hospitalized for various reasons; two children 
were excluded since they were hospitalized for unrelated conditions 
(appendicitis and burn). Fifty one (60.7%) of the eighty four 
admitted children were hospitalized in the first six months of ART 
initiation. Of the independent variables, only the presence of 
opportunistic infections and duration on ART were significantly 
associated with hospitalization both on bi-variable and 
multivariable analyses (P-value <0.05). As the duration on ART 
increased by one month, the risk of hospitalization decreased by 
5.4%, which is statistically significant (P < 0.001). Whereas the 
incidence (number) of OI’s increased by one, the risk of being 
hospitalized increased by 35.2% (P = 0.002). Of the individual 
opportunistic infections, pneumonia was found to be the only 
predictor of hospitalization (P-value = 0.002). 
Conclusion: This study showed that nearly two-third of the 
hospitalization was within 6 months of initiation of ART; and 
presence of OI and duration on ART were the only predictors of 
hospitalization. 
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The emergence of the HIV epidemic is one of the 
biggest public health challenges the world has 
ever seen in recent history. Since the confirmation 
of its existence HIV has affected all continents 
wildly spreading to children, adolescents and 
adults. Sub-Saharan Africa (SSA) is the epicenter 
of the epidemic and continues to carry the full 
brunt of its health and socioeconomic impact. 
Ethiopia is among the countries most affected by 
the HIV epidemic. With an estimated adult 
prevalence of 1.5%, Ethiopia has a large number 
of people living with HIV; and about 1 million 
AIDS orphans (1). 
Substantial progress has been made in the 
management of pediatric HIV infection 
worldwide, in SSA and Ethiopia with the 
implementation of mother-to-child-prevention 
programs. Early Infant diagnosis using DBS and 
subsequently the introduction of Highly Active 
Antiretroviral therapy (ART), however is lagging 
behind where an estimated 3.3 million children are 
still living with HIV, of whom 3.1 million live in 
sub-Saharan Africa. Although the exact 
prevalence of HIV in the children of Ethiopia is 
not known there are currently 134,586 children 
under 14 years living with HIV/AIDS (2).  
Mortality was high and premature before the 
introduction of HAART, reaching 35% in the first 
12 months of life and 52% within 2 years of life of 
HIV-infected infant (3). Since 2004, however, 
following the introduction of ART, reductions in 
mortality and morbidity among HIV-infected 
children have been reported (4- 8).  
Hospitalization represents an important 
outcome measure and a reliable indicator for 
morbidity and mortality, as well as health service 
utilization. The four leading causes of admission 
to Tikur Anbessa hospital pediatric emergency 
department were severe pneumonia (38.6%), 
meningitis (7.2%), sepsis (5.6%) and heart 
diseases (4.6%) (3,9). In an earlier study done in 
the same facility, malnutrition (18.5%), neonatal 
disorders (16.8%), diseases of the respiratory 
system including pneumonia (10.6%) and 
infective and parasitic diseases (9.8%) were the 
four major causes of admission to all the wards (4, 
10). 
Research elsewhere has shown that the rate of 
hospitalization is very high in children who are on 
HAART, particularly in the first 6 months of 
enrollment. For instance, in Thailand, Collins et al 
(2012) found hospitalization rates of 63 per 100 
person years in the first 6 months on ART, 
declining to 10 per 100 person years after two 
years on HAART. In another Thai study, (5,11) 
the incidence of hospitalization was found to be 
30.7% in the first six months of life, declining to 
2.0% by the third year of life. A Brazilian study 
(6,12) found that 43.3% of children were 
hospitalized in the first three years of therapy. 
Although investigators have looked into the 
patterns and causes of hospitalization in children, 
there are little or no published studies 
investigating predictors of hospitalization in 
children on HAART. 
The purpose of this study, therefore, was to assess 
predictors of hospitalized children on ART in 
seven university referral hospitals in Ethiopia. 
 
PATIENTS AND METHODS 
 
Background of Advanced Clinical Monitoring 
(ACM) of ART in Ethiopia: Seven public 
medical schools in Ethiopia; Addis Ababa, 
Defense, Gondar, Haromaya, Hawassa, Jimma, 
Makelle, Gondar and their affiliated hospitals 
agreed to establish an observational cohort study 
of HIV infected children and adults. The study 
was named the Advanced Clinical Monitoring 
(ACM) of ART in Ethiopia. The stakeholders 
were; The Federal Ministry of Health- represented 
by the Federal HIV/AIDS Prevention and Control 
Office (FHAPCO), the Ethiopian Health and 
Nutrition Research Institute (EHNRI) now 
renamed as Ethiopian Public Health Institute 
(EPHI) which hosted the central data and 
specimen repository, the Federal Science and 
Technology Commission (STC) the now renamed 
as Ministry of Science and Technology (FMoST), 
CDC-Ethiopia-the sponsors, and The Johns 
Hopkins University-Technical Support for 
Ethiopia on HIV/AIDS Initiative (JHU-TSEHAI) 
who provided technical assistance. The 
participating institutions signed a collaboration 
agreement in January 2006, and the project was 
formally launched in September 2006. However, 
enrolment of cases started in September 2009. 
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An ART Register Database of all children 
initiated on ART since January 2005 was 
developed and maintained at each site. Each 
participating center contributed 20 randomly 
selected children from the ART Register database; 
the repository cohort consisted of 20 children per 
site who were ART naïve on entry to the cohort. 
Similar database was set for adult cases which is 
inclusive of children age 15-18 years. Eligibility 
for ART was according to Federal Ministry of 
Health Ethiopia ART guideline. Children were 
enrolled to the cohort after written informed 
consent (age 14-18 years) and through their 
guardians (below ten years). Children from ten to 
thirteen years old were also verbally assented. 
Baseline socio demographic, clinical and 
laboratory data was recorded on medical forms 
that were standardized at all seven ACM 
participating sites. During the screening visit, 
participants had baseline medical and laboratory 
evaluation; while eligibility assessment for ART 
was made by site level physicians. Consenting 
patients were enrolled to the study and followed 
up at two and four weeks, at three months after 
starting of ART, and every three months 
thereafter. Data on adherence, ongoing clinical 
care, hospitalizations were recorded. Data was 
entered in to software called ART Information 
System for Ethiopia, ARTISE, at site level and 
then transported to the central database 
electronically. All identifying information was 
removed before transferring data. A participant 
was recorded as lost to follow up after she/he had 
missed two scheduled visits and couldn’t be 
contacted by telephone or through her/his 
emergency contact. Participants could withdraw 
from the database at any time by informing site 
staff.  
The national ethical clearance committee and 
IRBs of JHU and CDC gave approval to the study. 
Study design and Population: A longitudinal 
study design was a part of the multisite 
observational study. All children enrolled in the 
ACM pediatric database cohort and adolescents 
age 14-18 enrolled in the ACM adult and 
adolescent database cohort were included. 
Sample size calculations: All the 174 ART-
experienced eligible participants and 231 ART-
naïve participants who had been enrolled into the 
ACM till December 31, 2012 were considered 
(fig. 1). Missed values were excluded from the 
analysis list wise.  
From the database, data on hospitalization, 
background information at enrollment (Age, Sex, 
with whom the child is living), nutritional status at 
enrollment (Stunting, underweight, Wasting), 
laboratory monitoring  (CD4 immune status) and  
clinical findings (WHO stage at enrollment) and  
treatment from enrollment to end of data 
collection (co-trimoxazole preventive therapy, 
Isoniazid Preventive Therapy,  Duration of ART,  
Duration of ART before hospitalization, Regimen 
at enrollment)  were extracted.  In addition, data 
on reasons for hospitalization were extracted from 
the hospitalization abstraction sheet, 
Data Analysis: Descriptive analysis was done to 
explain each variable selected. Modeling was done 
using logistic regression. As an initial step, each 
factor’s association with hospitalization was 
analyzed in uni-variable logistic regression. All 
factors significant at P-value< 0.05 level was 
considered for the multi-variable analysis. 
Backward stepwise selection was used to identify 
independent factors associated with hospitalization 
in the multi-variable analysis. The data flow is 
shown in figure 1. 
The frequency and distribution of the 
hospitalized cases was tabulated by principal 
diagnostic category as listed on the discharge 
report, including opportunistic infections, non-
AIDS related conditions, immune reconstitution 
inflammatory syndrome (IRIS) and medication 
toxicities.  
The following operational definitions were used  
• Hospitalization: any child or adolescent  
admitted to the health facility during the 
course of ART due to opportunistic infections, 
IRIS, drug related events, other infections  and 
non-infectious illnesses with the exception of 
admission for procedures or accidents 
irrespective of duration of hospital stay.  
• Child and/or adolescent: an individual below 
the age of 18 years. 
• Opportunistic Infection (OI): any single or 
multiple  disease(s)  that occur(s) because of 
weakened immune system due to HIV 
infection [extensive molluscum contagiosum 
(5% body surface area),  herpes zoster, 
recurrent or chronic upper respiratory tract 
infection (URTI), fungal nail infections, 
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moderate or severe malnutrition, unexplained 
persistent diarrhea, unexplained persistent 
fever, oroesophageal candidiasis, oral hairy 
leukoplakia, acute necrotizing ulcerative 
gingivitis/ periodontitis, tuberculosis, severe 
pneumonia, lymphoid interstitial pneumonitis, 
unexplained anemia, thrombocytopenia and 
neutropenia, Pneumocystis carinii 
Pneumonitis (PCP), recurrent sever presumed 
bacterial infections, chronic herpes simples 
infection, Kaposi sarcoma, toxoplasmosis, 
HIV encephalopathy, CMV infection, 
cryptococcal meningitis, cerebral or B cell 
non-Hodgkin’s lymphoma]. 
• Immune Reconstitution Inflammatory 
Syndrome (IRIS):  is defined as evidence of 
favorable response to HAART with a 
temporal association between the initiation of 
HAART and onset of disease. 
• Drug related events: any unfavorable/ 
undesirable condition with possible 
relationship to ARVs. 
• Other infections: infections other than those 
listed under OI above. 
• Duration of ART: the duration of treatment 
from initiation of ART up to end of enrolment, 
December 31/2012. 
• Duration of ART before hospitalization-  the 
duration of ART treatment up to 
hospitalization 
• CD4 is classified as normal, moderate, and 
severe immune deficiency as per the 2009 
report of the committee of infectious disease, 
American Academy of Pediatrics (13). 
• Malnutrition: is the presence of underweight, 





During the cohort period, 405 children on ART, 
174 from experienced and 231 from naive were 
enrolled. Eighty six children (20.7%) were 
hospitalized for various reasons; two of them were 
not considered as hospitalized during our analysis 
since they were admitted for appendicitis and 
burn. Fifty one out of 84 (60.7%) children 
hospitalized for HIV/AIDS related causes were 
admitted in the first six months of ART initiation 
(fig. 1, table 1). The 405 children were from the 
seven participating university hospitals. The 
distribution of cases among participating facilities 







*During the analyses, the two non-HIV/AIDS related hospitalizations were considered as non-hospitalized.  
 
Figure 1: Flow chart showing distribution among different ACM cohort groups. 
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Table 1: Frequency of cases by facility and intra-cluster homogeneity analyses among the seven facilities. 
 
Facility  Hospitalized Non-Hospitalized        Odds    95% Conf. Interval 
Tikur Anbesa 12 57 0.211         0.113-0.392 
Army 10 32 0.313         0.154-0.636 
Gondar 18 52 0.346         0.203-0.592 
Jimma 11 42 0.262         0.135-0.509 
Mekelle 13 47 0.277         0.150-0.511 
Haramaya 7 44 0.159         0.072-0.353 
Hawassa 13 47 0.277         0.150-0.511 
Test of homogeneity (equal odds): chi
2
(6)  =  3.35,    Pr>chi
2
  =  0.7643,  
Score test for trend of odds:  chi
2
(1)  =  0.06,  Pr>chi
2
  =   0.8062 
 
Participants age was categorized based the 
national ART guideline age category. 
Accordingly, 260 (64.2) of the children were in 
the age group of 5-14 years with median age of 7 
years. Two hundred seventy three (84.5%) of the 
children were living with their parents and most of 
them 255(64.6%) were WHO stage III and IV at 
initiation of ART. Almost all were kept on first 
line ART regimen; nearly 80% of them on AZT 
based regimen. When we see the nutritional status 
of these children, 86(21.2%) were underweight, 74 
(18.3%) were stunted while 65 (17.8%) were 
wasted. Three hundred eighty (93.8%) of the 
children were on Cotrimoxazole and only 2% on 
isoniazid preventive therapy. One hundred forty 
five (45.2%) and 143 (44.5%) of the children had 
severe and moderate immune deficiency, 
respectively while only 10% had normal CD4 
count. One hundred seventy two (42.5%) of the 
children had at least one episode of opportunistic 
infections. For two variables (ART Regimen type 
at initiation and Wasting) values were missing 
since height for 36 and weight for 4 children were 
not recorded. For one child there was no record for 
the ART regimen type she was on at treatment 
initiation (table 2). 
Table 2. Background characteristics of children on ART in seven Ethiopian Referral  Hospitals. 
 
Variables Categories Frequency Percentage 
Hospitalization  Yes 84 20.7 
 
No 321 79.3 
Sex Male 207 51.1 
 
Female 198 48.9 
Age Category in year 0-4 117 28.9 
 
5-9 196 48.4 
 
10-18 92 22.7 
Child live with  Parents 273 84.5 
 
Others 50 15.5 
Baseline WHO Stage Stage I & II 140 35.4 
 
Stage III & IV 255 64.6 
ART Regimen at initiation
¥
 AZT or D4T+3TC+NVP 318 78.7 
 
AZT or D4T+3TC+EFV 70 17.3 
 
Other 1st line regimens 15 3.7 
Second line 1 0.3 
Under Weight Yes 86 21.2 
 
No 319 78.8 
Stunted Yes 74 18.3 
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No 331 81.7 
Wasted
¥
 Yes 65 17.8 
 No 300 82.2 
CPT Yes 380 93.8 
 
No 25 6.2 
IPT Yes 8 2.0 
 
No 397 98.0 
CD4 count at ART start Normal 33   10.3 
 Moderate 143 44.5 
 Severe 145 45.2 
OIs Yes 172 42.5 
 No 233 57.5 
¥
Values do not add up 405 as some information was not captured.  
In identifying the possible predictors of 
hospitalization from dependent variables, logistic 
regression was done. Accordingly, of the 
exploratory variables, using bi-variable analyses 
only showed the presence of opportunistic 
infections and duration on ART associated with 
hospitalization (table 3). 
 
Table 3. Association of background characteristics with hospitalization using bi-variable logistic regression 
 
    Hospitalization  
   
 
  
 Yes No 
   
 
Variables Categories N (%) N (%) COR 95% CI P-value 
Sex Female 36(18.2) 162(81.8) 1    
 
Male 48(23.2) 159(76.8) 1.36 0.84 2.21 0.215 
Age Category < 5 years 28(23.9) 89(76.1) 1 
   
 
5 - 9 years 40(20.4) 156(79.6) 0.82 0.47 1.41 0.465 
 
10 - 18 years 16(17.4) 76(82.6) 0.67 0.34 1.33 0.251 
Child live with Parents 60(22) 213(78) 1.28 0.59 2.79 0.529 
 
Others 9(18) 41(82) 1 
   
Baseline WHO 
Stage 
Stage I & II 23(16.4) 117(83.6) 0.65 0.38 1.11 0.117 
Stage III & IV 59(23.1) 196(76.9) 1 
   
ART Regimen at 
initiation 
AZT or D4T+3TC+NVP 66(20.8) 252(79.2) 1 
   
AZT or D4T+3TC+EFV 14(20) 56(80) 0.96 0.5 1.82 0.888 
Other 1st line regimens 4(26.7) 11(73.3) 1.39 0.43 4.5 0.584 
Under Weight Yes 19(22.1) 67(77.9) 1.11 0.62 1.98 0.728 
 
No 65(20.4) 254(79.6) 1 
   
Stunted Yes 18(24.3) 56(75.7) 1.29 0.71 2.34 0.401 
 
No 66(19.9) 265(80.1) 1 
   
Wasted Yes 18(27.7) 47(72.3) 1.71 0.92 3.16 0.09 
 
No 55(18.3) 245(81.7) 1 
   
CPT Yes 81(21.3) 299(78.7) 1 
   
 
No 3(12) 22(88) 0.5 0.15 1.72 0.274 
INH Yes 1(12.5) 7(87.5) 1 
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CD4 Category Severe 25(17.2) 120(82.8) 1 
   
 
Moderate 27(18.9) 116(81.1) 1.12 0.61 2.04 0.718 
 
Normal 8(24.2) 25(75.8) 1.54 0.62 3.79 0.353 
OI Yes 44(25.6) 128(74.4) 1.66 1.02 2.67 0.04 
  No 40(17.2) 193(82.8) 1 
   Number of OI's    1.23 1.06 1.4 0.006 
Duration on ART    0.93 0.91 0.95 <0.001 
 
The two variables- OIs and duration on ART 
remained to be strong predictors of hospitalization 
on multivariable analyses. As the duration on ART 
increased  by one month, the risk of 
hospitalization decreased by 5.4% which is 
statistically significant (P < 0.001). However, 
when the incidence (number) of OI’s increased by 
one, the risk of being hospitalized increased by 
35.2%, P = 0.002 (table 4). 
 
Table 4. Predictors of hospitalization among children on ART in Ethiopia 
 
Variables AOR 95% CI for AOR   P-Value 
Duration on ART in months 0.926 0.906 0.946 < 0.001 
OI_Count 1.352 1.122 1.631 0.002 
 
The study tried to identify which opportunistic 
infections could predict hospitalization. In doing 
so the commonly seen opportunistic infections 
were tallied and bi-variable regression done for 
hospitalization against the presence or presence of 
individual opportunistic infection and pneumonia 
was found to be the only predictor of 
hospitalization (P-value = 0.002) (table 5).  
 






Yes No  
 OI Type N (%) N (%) P-Value 
Pneumonia No 52(17.2) 251(82.8) 
0.002 
Yes 32(31.4) 70(68.6) 
Oral Candidiasis No 78(20.6) 301(79.4) 
0.761 
Yes 6(23.1) 20(76.9) 
Malnutrition No 71(20.1) 283(79.9) 
0.371 
Yes 13(25.5) 38(74.5) 
Other OI No 72(20.9) 272(79.1) 
0.823 
Yes 12(19.7) 49(80.3) 
 
Although there were over eleven disease 
categories as reasons for hospitalization, only 
three - acute respiratory infections, malnutrition 
and neurological problems accounted for 33 
(38.4%), 9 (10.5%) and 7 (8.2%), respectively 
(Fig 2). 
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Figure 2: Frequency distribution of causes of hospitalization 
DISCUSSION 
 
This Prospective Cohort study aimed to identify 
the predictors of hospitalization among children in 
Ethiopia. Eighty four children (20.7%) out of the 
total 405 in the study were hospitalized at least 
once for various reasons.  The result is similar to a 
study done in Thailand where 35% children were 
hospitalized (5). However, this study may not be 
representative to all children with HIV in Ethiopia 
as many others may be hospitalized in  district or 
regional hospitals. 
The majority of the children (60.7%) were 
admitted within the first 24 weeks of HAART 
initiation, which is not different from other similar 
studies. The median time of ART among those 
hospitalized in West Africa was 9.8 months (15). 
The first 6 months of treatment is characterized by 
high mortality of hospitalization until the patient 
gets stabilized (5).  
The mean age at HAART initiation in our 
study population was 7 years which is similar to 
the study done in Thailand where it was 7.6 years 
(5). This finding is a bit late than the one reported 
in West Africa where the HAART initiation age 
was 3 years (15). While HIV in children is known 
for its fast progression, the mortality is quiet high 
and if not treated timely.This study finding 
indicates that there has been delay in diagnosing 
and initiating HAART. The WHO reports that 
without treatment, 50% of children would die 
before their 2
nd
 birth day and if  delayed until 5 
years, 75% of them would die (16); emphasizing 
the need for early infant diagnosis and treatment. 
Malnutrition in the form of underweight, 
stunting or wasting based on the WHO Z-score 
was common among those children. Eighty six 
children (21.2%) were underweight, 18.3% 
stunted and 17.8% wasted. Malnutrition is 
considered to be the most common manifestation 
of HIV infected children in developing countries 
(17, 18). A study that dealt with clinical profile of 
hospitalized HIV –infected children in Bangladesh 
found   that for children below 5 years of age, the 
mean Weight for Age Z-score (WAZ) was -2.1 
and Height for Age Z-score (HAZ) HAZ was -2.9 
while for older than 5 years of age the mean BMI 
was 12.6 (19). 
More than half 44(52.4%) of those 
hospitalized had at least one episode of 
opportunistic infection (OI), while only 
128(39.9%) of those non-hospitalized had OI. 
Presence of OI was found to be associated with 
hospitalization with P-value of <0.05 using both 
bi-variable and multi-variable analysis. A study 
done among children and young adults in United 
States of America HIV clinics revealed that CD4 
count and HIV-1RNA were strongly associated 
with hospitalization (20). We don’t have data on 
viral load in most of our cases and the CD4 count 
(though few missing) was not found to be 
significantly associated with hospitalization. 
Presence of OI could be a proxy indicator of low 
CD4. 
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The other variable which was associated with 
hospitalization was duration on ART-the lesser the 
duration the higher the chance of getting 
hospitalized. This indicated that children were  
initiated late after they developed OIs and soon 
after treatment initiation  got hospitalized either 
due to the OIs or IRIS. Care interventions aiming 
at identifying the earliest possible HIV-infected 
infants and treating them according to current 
guidelines would drastically reduce cost of HIV 
care including costs related to hospitalization (15). 
Studies in Thailand and South Africa have shown 
that early ART initiation incur lower in patient 
care costs (21, 22).  
The major causes of hospitalization were 
pneumonia 33(38.1), malnutrition 9(10.5%) and 
neurological conditions like seizure and focal 
neurological deficits. Furthermore, this study also 
revealed pneumonia to be the single predicator of 
hospitalizations among OIs. Other studies also 
showed that pneumonia to be the leading cause of 
hospitalizations (5, 15). 
In conclusion, this cohort study showed that 
HAART initiation age was late, presence of OI 
and duration on ART were the only predictors of 
hospitalization and pneumonia was the leading 
cause of hospitalization. This study might not be 
generalized to all children enrolled in ART in 
Ethiopia such as those following at primary level 
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